Cargando…

Methodology and Initial Results From a Real-World Observational Cohort of Patients With Inflammatory Bowel Disease: TARGET-IBD

BACKGROUND: Data on care patterns for inflammatory bowel disease (IBD) from large-scale, diverse clinical cohorts in real-world practice are sparse. We developed a real-world cohort of patients receiving care at academic and community sites, for comparative study of therapies and natural history of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Click, Benjamin, Barnes, Edward L, Cohen, Benjamin L, Sands, Bruce E, Hanson, John S, Regueiro, Miguel, Rubin, David T, Dubinsky, Marla C, Gazis, Derek R, Dalfonso, Laura, Hildebrand, Janet S, Crawford, Julie M, Long, Millie D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Observations and Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802086/ https://www.ncbi.nlm.nih.gov/pubmed/36776639 http://dx.doi.org/10.1093/crocol/otab023

Ejemplares similares

Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD
por: Click, Benjamin, et al.
Publicado: (2022)

Trends and Characteristics of Clinical Trials Participation for Inflammatory Bowel Disease in the United States: A Report From IBD Partners
por: Johnson, Cole, et al.
Publicado: (2020)

Clinical Effect of Mirikizumab Treatment on Bowel Urgency in Patients with Moderately to Severely Active Ulcerative Colitis and the Clinical Relevance of Bowel Urgency Improvement for Disease Remission
por: Dubinsky, Marla C, et al.
Publicado: (2022)

Ethnicity Influences Risk of Inflammatory Bowel Disease (IBD)-Associated Colon Cancer: A Cross-sectional Analysis of Dysplasia Prevalence and Risk Factors in Hispanics and Non-Hispanic Whites With IBD
por: Damas, Oriana M, et al.
Publicado: (2021)

Development and Validation of the IBD-REFER Criteria: Early Referral for Suspected Inflammatory Bowel Diseases in Adults and Children
por: Atia, Ohad, et al.
Publicado: (2020)

Impact of Bowel Urgency on Quality of Life and Clinical Outcomes in Patients With Ulcerative Colitis
por: Dubinsky, Marla C, et al.
Publicado: (2022)

Factors Associated With Fecal Calprotectin Sample Collection Compliance: An IBD Center Quality Improvement Project
por: Fenton, David, et al.
Publicado: (2022)

Disease and Treatment Patterns Among Patients With Pouch-related Conditions in a Cohort of Large Tertiary Care Inflammatory Bowel Disease Centers in the United States
por: Barnes, Edward L, et al.
Publicado: (2020)

Home Infusions for Inflammatory Bowel Disease Are Safe: US Experience and Patient Perspectives
por: Kochar, Bharati, et al.
Publicado: (2021)

TELEmedicine for Patients With Inflammatory Bowel Disease (TELE-IBD) Does Not Improve Depressive Symptoms or General Quality of Life Compared With Standard Care at Tertiary Referral Centers
por: Schliep, Matthew, et al.
Publicado: (2020)

Low Health Literacy Exists in the Inflammatory Bowel Disease (IBD) Population and Is Disproportionately Prevalent in Older African Americans
por: Dos Santos Marques, Isabel C, et al.
Publicado: (2020)

Overuse of Tuberculosis Surveillance Testing in Patients With Inflammatory Bowel Disease Compared to Non-IBD Patients on Biologic Therapy
por: Fine, Sean, et al.
Publicado: (2021)

Dietary Patterns Are Not Associated With Disease Activity Among Patients With Inflammatory Conditions of the Pouch in a Prospective Cohort
por: Barnes, Edward L, et al.
Publicado: (2023)

The Real-World Global Use of Patient-Reported Outcomes for the Care of Patients With Inflammatory Bowel Disease
por: Horrigan, Jamie M, et al.
Publicado: (2023)

Tolerability of Bowel Preparation and Colonoscopy in IBD Patients: Results From a Prospective, Single-Center, Case–Control Study
por: Bezzio, Cristina, et al.
Publicado: (2020)

Treatment Patterns and Standardized Outcome Assessments Among Patients With Inflammatory Conditions of the Pouch in a Prospective Multicenter Registry
por: Barnes, Edward L, et al.
Publicado: (2022)

Inflammatory Bowel Disease Patients’ Perspectives of Clinical Trials: A Global Quantitative and Qualitative Analysis
por: Rubin, David T, et al.
Publicado: (2021)

Real-World Experience With Acute Infusion Reactions to Ustekinumab at 2 Large Tertiary Care Centers
por: Spencer, Elizabeth A, et al.
Publicado: (2020)

Patient-Centered Access to IBD Care: A Qualitative Study
por: Heisler, Courtney, et al.
Publicado: (2022)

A Systematic Review of Fecal Microbiota Transplant for the Management of Pouchitis
por: Kayal, Maia, et al.
Publicado: (2020)

Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug Monitoring
por: Hemperly, Amy, et al.
Publicado: (2021)

Real-World Effectiveness and Safety of Ustekinumab for Ulcerative Colitis From 2 Tertiary IBD Centers in the United States
por: Hong, Simon J, et al.
Publicado: (2021)

Characteristics of Fecal Microbiota Transplantation Use in Inflammatory Bowel Disease Cohort
por: Bauer, Christina M, et al.
Publicado: (2020)

Prevalence of Immunomodulator Use as Combination Therapy With Vedolizumab or Ustekinumab in Inflammatory Bowel Disease
por: Lutz, Megan, et al.
Publicado: (2023)

Changing Patterns of Relationships Between Geographic Markers and IBD: Possible Intrusion of Obesity
por: Szilagyi, Andrew, et al.
Publicado: (2020)

Thiopurine Exposure During Pregnancy is Not Associated With Anemia in Infants Born to Mothers With IBD
por: Yeaman, Fiona, et al.
Publicado: (2023)

Crohn’s Disease Patient Experiences and Preferences With Disease Monitoring: An International Qualitative Study
por: Rohatinsky, Noelle, et al.
Publicado: (2023)

Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients
por: Spencer, Elizabeth A, et al.
Publicado: (2021)

Use of Standardized Inflammatory Bowel Disease Endoscopy Scores in Clinical Practice
por: Gaidos, Jill K J, et al.
Publicado: (2023)

Low Skeletal Muscle Index Adjusted for Body Mass Index Is an Independent Risk Factor for Inflammatory Bowel Disease Surgical Complications
por: Berger, Matthew, et al.
Publicado: (2020)

Poor Baseline Health of IBD Patients at Presentation to a Surgeon: Results From a Patient-Reported Outcomes Database
por: Sacks, Olivia A, et al.
Publicado: (2021)

A Patient-Prioritized Agenda for Information Needs During the COVID-19 Pandemic: A Qualitative Study of Patients With Inflammatory Bowel Disease
por: Long, Millie D, et al.
Publicado: (2021)

Prevalence of Obstructive Sleep Apnea Is Increased in Patients With Inflammatory Bowel Disease: A Large, Multi-Network Study
por: Hoffman, Kyle, et al.
Publicado: (2022)

Functional Molecular Network Analysis Enables Prediction of Response to Vedolizumab Therapy in Anti-TNF Refractory IBD Patients
por: Breidert, Matthias, et al.
Publicado: (2020)

IBD Camp Oasis: A look at Participants’ Social-Emotional Well-Being and Protective Factors During Camp and Beyond
por: Singh, Namita, et al.
Publicado: (2023)

Identification of Risk Factors for Coexisting Sinusitis and Inflammatory Bowel Disease
por: Rai, Victoria, et al.
Publicado: (2021)

Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease
por: Alayo, Quazim A, et al.
Publicado: (2022)

Inflammatory Bowel Disease: Changing Associations to Mechanisms
por: Click, Benjamin, et al.
Publicado: (2016)

Risks of Development of COVID-19 Among Patients With Inflammatory Bowel Disease: A Comparative Assessment of Risk Factors for Incident Infection
por: Long, Millie D, et al.
Publicado: (2022)

The Early Experience With Vedolizumab in the United States
por: Kochar, Bharati, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f3bjob78gciuu7khadadeeu1pm